Michael James Newman is CSO and Director of Indaptus Therapeutics, Inc.. Currently has a direct ownership of 101,074 shares of INDP, which is worth approximately $253,695. The most recent transaction as insider was on Dec 22, 2025, when has been sold 52,204 shares (Common Stock) at a price of $2.03 per share, resulting in proceeds of $105,974. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 101K
n/a 3M change
n/a 12M change
Total Value Held $253,695

Michael James Newman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2025
BUY
Grant, award, or other acquisition
$105,974 $2.03 p/Share
52,204 Added 34.06%
101,074 Common Stock
MJN

Michael James Newman

CSO and Director
New York, NY

Track Institutional and Insider Activities on INDP

Follow Indaptus Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INDP shares.

Notify only if

Insider Trading

Get notified when an Indaptus Therapeutics, Inc. insider buys or sells INDP shares.

Notify only if

News

Receive news related to Indaptus Therapeutics, Inc.

Track Activities on INDP